Now let me search for calibration papers.Now I have enough information to write the final review. Let me synthesize everything.

---

## Summary
AnyECG is a family of ECG foundation models (254M–1.7B parameters) built on a two-stage self-supervised pre-training pipeline: (1) an ECG Tokenizer with a VQ-based Rhythm Codebook and Multi-View Synergistic Decoder (morphology, frequency, demography supervision) to produce noise-resilient discrete tokens, and (2) a masked pre-training stage over these tokens using a novel Cross-Mask Attention (CMA) mechanism. The system targets four downstream tasks: anomaly detection, arrhythmia detection, corrupted lead generation, and ultra-long ECG recognition.

---

## Strengths

- **Novel ECG Tokenizer architecture** (Section 2.2, Eq. 2–8): The combination of a VQ Rhythm Codebook using normalized cosine similarity with a Multi-View Synergistic Decoder that simultaneously reconstructs time-domain morphology, DWT-based frequency coefficients, and patient demographics is a principled, domain-informed design not seen in prior ECG foundation models.

- **Physiologically motivated Cross-Mask Attention** (Eq. 1, Figure 1): CMA restricts patch interactions to the same lead or the same temporal position across leads, encoding the physiological reality that ECG leads at the same cardiac cycle instant carry complementary information. The positional tolerance parameter explicitly models conduction delays.

- **Two-stage discrete-target pre-training** (Eq. 9): Rather than reconstructing raw, noisy signal values, the masked pre-training stage predicts Rhythm Code indices, forcing the backbone to learn high-level rhythm-event associations rather than memorizing noise—an improvement over standard reconstruction-based self-supervised approaches for low-SNR signals.

- **Scale of the model family and reliability of reporting**: Three model sizes (254M, 500M, 1.7B), evaluated across four heterogeneous tasks with five-seed averaging and standard deviations. The 1.7B AnyECG-XL is the largest ECG model reported to date.

---

## Weaknesses

### Fatal
None.

### Major

- **In-distribution pre-training advantage over all non-pre-trained baselines**: AnyECG is pre-trained on all seven datasets listed in Table 1, which are the same datasets from which downstream evaluation splits are drawn. The competing baselines (DENS-ECG, ContraWR, XResNet1D, RNN1D, FFCL, InceptionID, ST-Transformer, CNN-Transformer) are trained only on the downstream training split and have never seen the evaluation distribution. The paper inadvertently acknowledges this confound when explaining ECG-FM's underperformance: "its performance may still be hindered by substantial differences between the pre-training data and the downstream task dataset"—the exact opposite of AnyECG's situation. Without a controlled experiment where another pre-trained baseline (e.g., ECG-FM or a standard MAE) is pre-trained on the same seven-dataset corpus, it is impossible to determine whether the observed improvements stem from the proposed architectural innovations (VQ codebook, CMA, multi-view decoder) or simply from in-distribution pre-training data access. This is the most important missing experiment; it undermines the paper's central architectural claims.

- **Asymmetric comparison in ultra-long ECG recognition (Table 5)**: All AnyECG variants carry a "✓" in the Adaptation column (hierarchical sliding-window method), while all baselines carry "✗"—meaning baselines are evaluated on a task they structurally cannot perform. Processing ultra-long sequences IS the core challenge of this task. The claimed superiority is an artifact of this asymmetry, not a demonstration of representational quality. Providing baselines with a simple windowed inference + pooling scheme would yield a meaningful lower bound; without it, Table 5 does not constitute a valid architecture comparison.

- **Severely weak baselines in corrupted lead generation (Table 4)**: The only comparisons are CGAN (Mirza, 2014) and WGAN (Adler & Lunz, 2018)—decade-old general-purpose generative models not designed for ECG lead reconstruction. No contemporary ECG-specific lead imputation methods are included. Claiming state-of-the-art generation performance against only two such baselines is not credible for a 2024–2025 foundation model paper. Furthermore, AnyECG-XL regresses relative to AnyECG-L on both PSNR (32.43 vs. 32.74) and SSIM (0.853 vs. 0.874), a non-monotone scaling behavior that is never discussed—raising questions about stability or evaluation power.

### Minor

- **Undisclosed pre-training dataset** (Table 1): 10,000 recordings ("Undisclosed Dataset," ~19% of total recordings) are used in pre-training with no source, geographic origin, clinical annotation schema, or sampling rationale provided. This limits reproducibility and prevents any meaningful assessment of data contamination with evaluation sets.

- **Absolute performance in arrhythmia detection is alarmingly low and unexplained** (Table 3): AnyECG-XL achieves 0.345 accuracy and 0.164 AUC-PR, and the paper frames these as evidence of "strong ability to handle arrhythmia detection." While the multi-class nature of the task may explain the low absolute values (high class imbalance, many classes), the paper never provides class-level breakdown, reports the number of classes, or discusses the clinical interpretability of these numbers. A per-class analysis is essential to determine whether these scores reflect a structurally failing model or a difficult label distribution.

- **Train/test split procedure does not mention patient-level separation**: The paper states an "80/20 split" for all downstream tasks but does not clarify whether splits are stratified by patient ID. For datasets like PTB-XL and INCART where multiple recordings per patient exist, recording-level splits can cause patient-level leakage and inflate downstream results.

- **"Minimal pre-processing" claim is misleading**: Section 2.1 uses this phrase, yet 1000 Hz signals (e.g., PTB) are downsampled 3.3× to 300 Hz. Diagnostic waveform morphology features (QRS rise time, P-wave fine structure) depend on temporal resolution. While the Nyquist justification for 300 Hz is provided, this should not be characterized as "minimal."

- **Demography decoder treats heterogeneous attributes uniformly** (Eq. 6): A single MSE loss over a vector `a` conflates continuous attributes (age, weight) with binary ones (sex). No normalization, loss weighting, or handling of missing demographic labels across the heterogeneous datasets is described. Datasets like INCART (74 recordings) may lack these attributes entirely.

### Trivial
- The positional tolerance (mask width) hyperparameter in CMA is mentioned as important "for certain diseases" but no guidance or ablation is provided in the main text for how to set it.

---

## Nice-to-Haves

- **Pre-train a controlled baseline on the same seven-dataset corpus**: This is the single most impactful experiment the authors could add—pre-train ECG-FM or a standard MAE on the identical data and compare. Without this, the architectural contributions cannot be isolated.
- **Codebook utilization analysis**: VQ training is susceptible to collapse (most entries unused). An analysis of per-code usage distribution, along with qualitative alignment of codebook entries to clinical ECG features (P-wave, QRS, T-wave), would significantly strengthen the interpretability claims.
- **Ablation studies in the main paper**: The paper defers all ablations to appendices 7.3/7.4. Bringing the core ablation (removing VQ, removing demographic supervision, removing CMA) into the main text would allow readers to directly evaluate each contribution.
- **Evaluation on a fully held-out dataset**: A geographically distinct or device-distinct ECG dataset not included in pre-training would provide a genuine test of cross-distribution generalization for a claimed "foundational" model.

---

## Removed Points

*These points are flagged to be removed; treat them with caution.*

- **Mask ratio and block size missing from main text** (Harsh critic, Section 2.3): The appendix is stripped by the parser; these details may be specified there. Removed per the rule against reproducibility nitpicks that could be in the appendix.
- **Claims about model availability/existence**: No reviewer raised concerns of this type; nothing to remove here.
- **Generic "problem is important" strength**: Removed the generic framing that ECG analysis is medically important as a standalone strength; this is not specific to the paper.

---

## Novel Insights

The most incisive observation from the reviews—not explicitly foregrounded in the paper itself—is the structural tension between AnyECG's "foundational model" framing and its evaluation design: a true foundation model should be evaluated on domains it has **not** seen during pre-training, yet all evaluation datasets overlap with pre-training data, and the only comparison to another pre-trained model (ECG-FM) is deliberately disadvantaged by a domain mismatch in the opposite direction. The paper has inadvertently constructed an experiment that can only show that in-distribution pre-training beats no pre-training, which is unsurprising. The non-monotone scaling (XL < L) on lead generation further hints that performance gains at scale may be fragile. The paper would be substantially stronger if it reframed its evaluation to include at least one held-out distribution.

---

## Suggestions

1. Add a controlled comparison: pre-train any existing ECG SSL method on the same seven-dataset corpus and compare on all four downstream tasks.
2. Equip all baselines in Table 5 with the same sliding-window adaptation before claiming ultra-long superiority.
3. Include at least two post-2020 ECG lead imputation or reconstruction baselines in Table 4.
4. Disclose the source of the undisclosed dataset or exclude it from pre-training in the evaluation version of the paper.
5. Add per-class breakdown for arrhythmia detection; report the number of classes and label frequencies.
6. Clarify whether train/test splits are patient-stratified.

---

## Score and Decision

**Calibration anchors:**

| Paper | Path | Avg Score | Comparison |
|---|---|---|---|
| LaBraM (EEG VQ + masked pre-training) | QzTpTRVtrP.md | **7.33** (spotlight) | Most similar approach; stronger: ablations, OOD eval, code release, no undisclosed data |
| NeuroLM (EEG VQ + LLM instruction tuning) | Io9yFt7XH7.md | **6.25** (poster) | Similar architecture philosophy; weaker OOD eval but cleaner comparison structure |
| PaPaGei (PPG foundation model) | kYwTmlq6Vn.md | **6.25** (poster) | Same paradigm; stronger: 20 tasks, 10 diverse datasets, open data, bias eval |
| TA-PCLR (ECG contrastive pretraining) | 7zJDTnogdG.md | **3.33** (reject) | Similar domain; rejected for weak analysis, no OOD validation—less severe flaws than AnyECG's evaluation design |
| CuPID (single-lead ECG masked modeling) | QjrC77Nyu6.md | **2.50** (reject) | ECG SSL, rejected for narrow scope and missing baselines |
| DASFormer (signal SSL for earthquake) | 7ipjMIHVJt.md | **5.25** (reject) | Physiological signal SSL with anomaly detection—comparable scope |

**Reasoning:** AnyECG has a genuinely novel architecture and addresses a real problem with scale (1.7B parameters, 7 datasets, 4 tasks). This places it well above CuPID/TA-PCLR in scope and ambition. However, its three major evaluation design issues (in-distribution pre-training advantage, asymmetric ultra-long comparison, archaic generation baselines) are more severe than the issues that caused NeuroLM/PaPaGei to land at 6.25. LaBraM at 7.33 had clean comparisons and released code. AnyECG's comparison structure is fundamentally weaker: the core architectural claims cannot be validated with the current evaluation design. This places the paper below NeuroLM and PaPaGei, closer to the DASFormer range (~5) but pulled down by the more systemic evaluation concerns. I settle on **4.5**: the approach is worth publishing in some form, but the evaluation design must be substantially revised before the architectural claims can be trusted.

**Final Score: 4.5 — Reject (major revision required)**

MY FINAL SCORE: <pineapple>4.5</pineapple>
MY FINAL DECISION: <orange>Reject</orange>